Porvair Sciences has launched a new range of pipette tip filters that provide the ability to block out contaminants.

Arctoris, the team behind the world’s first fully automated, robotic laboratory dedicated to drug discovery, has secured further investment.

A new institute aims to champion the latest approaches to research on research.

Thermo Fisher Scientific has announced a new cell expansion medium, providing researchers with more functional cells for cell therapy applications.

St George Street Capital (SGSC) has signed an agreement with AstraZeneca to develop two compounds in the clinic: one for idiopathic male infertility, and the other for renal transplant rejection.

AMSBIO have introduced a new range of reagents designed for researchers investigating targeted cancer therapy.

AstraZeneca have invested in a LyoConstellationTM S10 freeze dryer, intended to help drive research and development of small scale GMP production.

New environmental chambers from Thermo Fisher Scientific replicate light, temperature and humidity conditions, while offering customization options.

A 3-D model of human blood vessels has been demonstrated to accurately assess a key stage in the development of inflammation and vascular disorders.

Bluestar Genomics are to share their new non-invasive data for earlier cancer detection at the 11th CNAPs International Symposium.